News

Soligenix HyBryte Phase 3 FLASH2 Trial Shows Interim Results for Cutaneous T-Cell Lymphoma Treatment

2 min

Avicanna Welcomes U.S. Cannabis Rescheduling Decision, Advances Medical Cannabis R&D Strategy

2 min

InnoCare Pharma Begins Phase III Trial of Orelabrutinib for Systemic Lupus Erythematosus Treatment

2 min

Orca Bio's Orca-Q Receives FDA RMAT Designation for High-Risk Blood Cancers Treatment

FDA · 2 min

FormBlends Releases 2026 Peptide Report as RFK-Era HHS Reshapes GLP-1 Therapy Access

2 min

C-Ray Therapeutics Receives FDA Acceptance for Copper-64 Drug Master File, Advancing Radiopharmaceutical Development

FDA · 2 min

BRC Therapeutics Receives FDA Clearance for BRC-002 Phase I Trial in Complex Regional Pain Syndrome

FDA · 2 min

Vanda Pharmaceuticals' Imsidolimab Shows Efficacy for Generalized Pustular Psoriasis in NEJM Evidence Study

2 min

AstraZeneca's BREZTRI Aerosphere Approved as First Triple Therapy for Asthma in Patients 12 and Older

2 min

Vensica Medical Receives FDA IND Approval for Phase 2 Trial of ViXe Needle-Free Xeomin Delivery System

2 min

AbbVie Submits FDA Application for Upadacitinib (RINVOQ) to Treat Severe Alopecia Areata

FDA · 2 min

Novartis Reports Strong Q1 2026 Growth Led by Remibrutinib CHMP Approval and Pipeline Advances

2 min